
THG Boston Consulting Group Matrix
THG’s BCG Matrix preview highlights where core divisions likely sit amid shifting market share and growth—spotting potential Stars in beauty and Question Marks in nutrition. This snapshot shows resource drains and cash-generating segments but lacks quadrant-level detail and actionable moves. Purchase the full BCG Matrix to get a complete Word report and Excel summary with precise placements, data-backed strategic recommendations, and ready-to-use visuals to guide investment and portfolio decisions.
Stars
As of late 2025, THG Beauty Prestige (Cult Beauty, Lookfantastic) sits in the BCG Stars quadrant, holding ~22% share of Europe's online premium beauty market and driving estimated FY2025 GMV of £620m across Europe and North America.
They lead traffic and high-value baskets (AOV ~£85) but need ongoing marketing spend—THG reported ~13% of FY2025 revenue reinvested in digital acquisition—to defend growth versus Sephora, Amazon and niche DTC brands.
The strategy is to convert rapid growth into high-margin cash cows by improving retention (LTV:CAC target 4:1) and raising gross margins from ~42% toward 48% through private-label expansion and supply-chain gains.
Myprotein remains the world’s leading online sports-nutrition brand, reporting ~£500m revenue in 2024 and double-digit growth in Asia (APAC +28% YoY) and Middle East (MENA +34% YoY), so in BCG it sits as a Star.
The brand has expanded into lifestyle categories (apparel, food, wellness) and needs heavy capex for localized manufacturing and marketing; estimated incremental investment: £60–90m through 2026 to scale local supply chains.
With a high market share in premium nutrition (~22% UK online market; top-3 in key EU markets), Myprotein is THG’s primary value driver, and continued investment is essential to defend against fast-growing niche health entrants.
The THG Ingenuity platform is a Star: by late 2025 it achieved >40% market share in specialized DTC infrastructure for large retailers and shifted to a recurring-revenue model that now represents ~55% of external SaaS bookings, driving 2025 external SaaS revenue of ~£180m.
Ingenuity consumes high R and D spend—about £60m in 2024–25—focused on AI-driven logistics and personalization, keeping gross margins near 65% while scaling enterprise ARR and retention above 90%.
Success in Ingenuity is critical to THG’s long-term valuation and tech-first transition, supporting a strategic reweighting of group value from retail inventory to high-margin platform revenue and recurring cash flows.
Premium Skincare Portfolio
Owned luxury skincare brands Perricone MD and ESPA sit as Stars in THG’s BCG matrix, targeting a high-growth dermatological-efficacy niche; global prestige skincare grew ~7.2% CAGR 2019–24 and professional channels outpaced retail, per Euromonitor 2024.
These brands hold leading share in prestige/pro channels and report strong YoY growth—THG cited combined beauty growth >20% in FY2024—yet need heavy promotion and influencer spend to keep visibility.
As category matures, margin expansion is likely: lower CAC and sustained repeat rates should convert them into high-profit Cash Cows with reduced marketing intensity by 2027.
- High-growth niche: ~7.2% CAGR (2019–24)
- THG beauty growth: >20% YoY (FY2024)
- Requires sustained influencer/promo spend now
- Profitability likely to rise by 2027 as market matures
Asia-Pacific Market Penetration
THG's APAC operations are a Star: e-commerce in the region grew ~18% CAGR 2019–2024 and THG has built logistics hubs in Singapore and Malaysia to capture that growth.
The group holds a leading share of cross-border prestige beauty into China and Southeast Asia, handling an estimated 12–15% of UK-to-Asia beauty imports in 2024.
Maintaining this position needs continued capex: THG invested ~£45m in APAC supply chain and compliance 2023–2025 to boost resilience and meet complex regulations.
APAC remains a key growth engine for THG into 2026, targeting double-digit revenue growth from the region.
- 18% APAC e‑commerce CAGR (2019–2024)
- 12–15% share of UK→Asia prestige beauty (2024)
- £45m capex in APAC supply chain (2023–2025)
- Targeting double‑digit APAC revenue growth into 2026
THG Stars (Beauty Prestige, Myprotein, Ingenuity, Perricone/ESPA, APAC) drive high growth: FY2025 GMV ~£620m (Beauty), Myprotein £500m (2024), Ingenuity external SaaS £180m (2025), group APAC capex £45m (2023–25); targets: LTV:CAC 4:1, gross margins rising ~42%→48%, £60–90m Myprotein capex to 2026.
| Asset | Key metric | 2024–25 figure |
|---|---|---|
| Beauty Prestige | GMV / EU share | £620m / ~22% |
| Myprotein | Revenue / APAC growth | £500m / +28% APAC |
| Ingenuity | External SaaS | £180m / >40% market |
| APAC ops | Capex / import share | £45m / 12–15% |
What is included in the product
Comprehensive BCG Matrix review of THG’s portfolio with quadrant strategies, investment recommendations, and trend-driven risks/opportunities.
One-page THG BCG Matrix placing each business unit in a quadrant for quick strategic clarity
Cash Cows
Lookfantastic UK Core sits in the Cash Cows quadrant: mature UK operations hold a dominant market share and steady low-single-digit growth, generating consistent high-volume cash flow—THG reported Beauty division UK revenue of £380m in FY2024, providing predictable EBITDA margins near 15%.
In the UK and Western Europe Myprotein is a mature cash cow for THG, holding a leading share in sports nutrition—estimated ~25–30% UK market share in 2024—and showing low single-digit top-line growth in 2024–25. Margins improved to roughly 14–16% EBITDA in 2024 as scale and vertical integration cut COGS. The unit’s free cash flow funded debt service (THG net debt ~£200m end-2024) and financed Ingenuity expansion. It remains THG’s most reliable internal funding source for strategic projects.
The THG Experience division, covering luxury hotels and events such as Hale Country Club, sits in a mature market with low growth but a stable customer base; in FY2024 it generated an estimated £45–55m EBITDA, reflecting high service margins and physical brand touchpoints.
These assets need modest capex versus THG’s digital units—capex approx £8–12m in 2024—so they return steady cash flow and diversify revenue, supporting lifestyle branding for core retail lines.
Subscription Box Services
The beauty box subscription model has plateaued in market growth but remains a high-share segment for THG, delivering predictable monthly revenue—THG reported recurring revenue contribution of ~£120m in 2024 from subscriptions across its platforms.
These services act as low-cost customer acquisition for THG’s wider retail sites; customer acquisition cost (CAC) is ~£12 versus £45 for paid channels, because the offer is well-understood by existing subscribers.
Marketing costs are relatively low and churn is managed around 22% annualized; the operational focus is on improving fulfillment and supplier terms to lift margins above the current ~18% gross on boxes.
- Recurring revenue: ~£120m (2024)
- CAC: ~£12 vs £45 for paid channels
- Annual churn: ~22%
- Target gross margin: >18% via ops efficiency
Vertical Manufacturing Facilities
THG’s vertical manufacturing for nutrition and beauty cuts COGS by about 15–20%, turning steady internal demand into high-margin cash flow; in FY2024 the sites ran near 88% capacity, keeping gross margins on owned brands above peer averages.
Owning production captures manufacturing margin otherwise paid to contract manufacturers, reduces supplier risk, and needs mainly maintenance capex (~2–3% of plant value annually), so cash retention per unit rises.
- COGS reduction ~15–20%
- Capacity utilization ~88% (FY2024)
- Maintenance capex ~2–3% plant value
- Higher gross margin vs peers
Lookfantastic, Myprotein, THG Experience and subscriptions act as THG cash cows, generating recurring cash (Beauty UK £380m, subscriptions ~£120m, Myprotein ~25–30% UK share) with EBITDA ~14–16% (Myprotein) and ~15% (Beauty UK); capex modest (£8–12m total, plants maintenance 2–3%), net debt ~£200m end-2024, CAC ~£12, churn ~22%, COGS cut ~15–20% via vertical manufacturing.
| Metric | 2024 |
|---|---|
| Beauty UK rev | £380m |
| Subscriptions | ~£120m |
| Myprotein UK share | 25–30% |
| EBITDA margins | 14–16% |
| Net debt | ~£200m |
| CAC | £12 |
| Churn | 22% |
| Capex | £8–12m |
| COGS reduction | 15–20% |
Preview = Final Product
THG BCG Matrix
The file you're previewing on this page is the exact THG BCG Matrix report you'll receive after purchase—no watermarks, no demo content—fully formatted and analysis-ready for immediate use in presentations or strategic planning.
Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
THG’s BCG Matrix preview highlights where core divisions likely sit amid shifting market share and growth—spotting potential Stars in beauty and Question Marks in nutrition. This snapshot shows resource drains and cash-generating segments but lacks quadrant-level detail and actionable moves. Purchase the full BCG Matrix to get a complete Word report and Excel summary with precise placements, data-backed strategic recommendations, and ready-to-use visuals to guide investment and portfolio decisions.
Stars
As of late 2025, THG Beauty Prestige (Cult Beauty, Lookfantastic) sits in the BCG Stars quadrant, holding ~22% share of Europe's online premium beauty market and driving estimated FY2025 GMV of £620m across Europe and North America.
They lead traffic and high-value baskets (AOV ~£85) but need ongoing marketing spend—THG reported ~13% of FY2025 revenue reinvested in digital acquisition—to defend growth versus Sephora, Amazon and niche DTC brands.
The strategy is to convert rapid growth into high-margin cash cows by improving retention (LTV:CAC target 4:1) and raising gross margins from ~42% toward 48% through private-label expansion and supply-chain gains.
Myprotein remains the world’s leading online sports-nutrition brand, reporting ~£500m revenue in 2024 and double-digit growth in Asia (APAC +28% YoY) and Middle East (MENA +34% YoY), so in BCG it sits as a Star.
The brand has expanded into lifestyle categories (apparel, food, wellness) and needs heavy capex for localized manufacturing and marketing; estimated incremental investment: £60–90m through 2026 to scale local supply chains.
With a high market share in premium nutrition (~22% UK online market; top-3 in key EU markets), Myprotein is THG’s primary value driver, and continued investment is essential to defend against fast-growing niche health entrants.
The THG Ingenuity platform is a Star: by late 2025 it achieved >40% market share in specialized DTC infrastructure for large retailers and shifted to a recurring-revenue model that now represents ~55% of external SaaS bookings, driving 2025 external SaaS revenue of ~£180m.
Ingenuity consumes high R and D spend—about £60m in 2024–25—focused on AI-driven logistics and personalization, keeping gross margins near 65% while scaling enterprise ARR and retention above 90%.
Success in Ingenuity is critical to THG’s long-term valuation and tech-first transition, supporting a strategic reweighting of group value from retail inventory to high-margin platform revenue and recurring cash flows.
Premium Skincare Portfolio
Owned luxury skincare brands Perricone MD and ESPA sit as Stars in THG’s BCG matrix, targeting a high-growth dermatological-efficacy niche; global prestige skincare grew ~7.2% CAGR 2019–24 and professional channels outpaced retail, per Euromonitor 2024.
These brands hold leading share in prestige/pro channels and report strong YoY growth—THG cited combined beauty growth >20% in FY2024—yet need heavy promotion and influencer spend to keep visibility.
As category matures, margin expansion is likely: lower CAC and sustained repeat rates should convert them into high-profit Cash Cows with reduced marketing intensity by 2027.
- High-growth niche: ~7.2% CAGR (2019–24)
- THG beauty growth: >20% YoY (FY2024)
- Requires sustained influencer/promo spend now
- Profitability likely to rise by 2027 as market matures
Asia-Pacific Market Penetration
THG's APAC operations are a Star: e-commerce in the region grew ~18% CAGR 2019–2024 and THG has built logistics hubs in Singapore and Malaysia to capture that growth.
The group holds a leading share of cross-border prestige beauty into China and Southeast Asia, handling an estimated 12–15% of UK-to-Asia beauty imports in 2024.
Maintaining this position needs continued capex: THG invested ~£45m in APAC supply chain and compliance 2023–2025 to boost resilience and meet complex regulations.
APAC remains a key growth engine for THG into 2026, targeting double-digit revenue growth from the region.
- 18% APAC e‑commerce CAGR (2019–2024)
- 12–15% share of UK→Asia prestige beauty (2024)
- £45m capex in APAC supply chain (2023–2025)
- Targeting double‑digit APAC revenue growth into 2026
THG Stars (Beauty Prestige, Myprotein, Ingenuity, Perricone/ESPA, APAC) drive high growth: FY2025 GMV ~£620m (Beauty), Myprotein £500m (2024), Ingenuity external SaaS £180m (2025), group APAC capex £45m (2023–25); targets: LTV:CAC 4:1, gross margins rising ~42%→48%, £60–90m Myprotein capex to 2026.
| Asset | Key metric | 2024–25 figure |
|---|---|---|
| Beauty Prestige | GMV / EU share | £620m / ~22% |
| Myprotein | Revenue / APAC growth | £500m / +28% APAC |
| Ingenuity | External SaaS | £180m / >40% market |
| APAC ops | Capex / import share | £45m / 12–15% |
What is included in the product
Comprehensive BCG Matrix review of THG’s portfolio with quadrant strategies, investment recommendations, and trend-driven risks/opportunities.
One-page THG BCG Matrix placing each business unit in a quadrant for quick strategic clarity
Cash Cows
Lookfantastic UK Core sits in the Cash Cows quadrant: mature UK operations hold a dominant market share and steady low-single-digit growth, generating consistent high-volume cash flow—THG reported Beauty division UK revenue of £380m in FY2024, providing predictable EBITDA margins near 15%.
In the UK and Western Europe Myprotein is a mature cash cow for THG, holding a leading share in sports nutrition—estimated ~25–30% UK market share in 2024—and showing low single-digit top-line growth in 2024–25. Margins improved to roughly 14–16% EBITDA in 2024 as scale and vertical integration cut COGS. The unit’s free cash flow funded debt service (THG net debt ~£200m end-2024) and financed Ingenuity expansion. It remains THG’s most reliable internal funding source for strategic projects.
The THG Experience division, covering luxury hotels and events such as Hale Country Club, sits in a mature market with low growth but a stable customer base; in FY2024 it generated an estimated £45–55m EBITDA, reflecting high service margins and physical brand touchpoints.
These assets need modest capex versus THG’s digital units—capex approx £8–12m in 2024—so they return steady cash flow and diversify revenue, supporting lifestyle branding for core retail lines.
Subscription Box Services
The beauty box subscription model has plateaued in market growth but remains a high-share segment for THG, delivering predictable monthly revenue—THG reported recurring revenue contribution of ~£120m in 2024 from subscriptions across its platforms.
These services act as low-cost customer acquisition for THG’s wider retail sites; customer acquisition cost (CAC) is ~£12 versus £45 for paid channels, because the offer is well-understood by existing subscribers.
Marketing costs are relatively low and churn is managed around 22% annualized; the operational focus is on improving fulfillment and supplier terms to lift margins above the current ~18% gross on boxes.
- Recurring revenue: ~£120m (2024)
- CAC: ~£12 vs £45 for paid channels
- Annual churn: ~22%
- Target gross margin: >18% via ops efficiency
Vertical Manufacturing Facilities
THG’s vertical manufacturing for nutrition and beauty cuts COGS by about 15–20%, turning steady internal demand into high-margin cash flow; in FY2024 the sites ran near 88% capacity, keeping gross margins on owned brands above peer averages.
Owning production captures manufacturing margin otherwise paid to contract manufacturers, reduces supplier risk, and needs mainly maintenance capex (~2–3% of plant value annually), so cash retention per unit rises.
- COGS reduction ~15–20%
- Capacity utilization ~88% (FY2024)
- Maintenance capex ~2–3% plant value
- Higher gross margin vs peers
Lookfantastic, Myprotein, THG Experience and subscriptions act as THG cash cows, generating recurring cash (Beauty UK £380m, subscriptions ~£120m, Myprotein ~25–30% UK share) with EBITDA ~14–16% (Myprotein) and ~15% (Beauty UK); capex modest (£8–12m total, plants maintenance 2–3%), net debt ~£200m end-2024, CAC ~£12, churn ~22%, COGS cut ~15–20% via vertical manufacturing.
| Metric | 2024 |
|---|---|
| Beauty UK rev | £380m |
| Subscriptions | ~£120m |
| Myprotein UK share | 25–30% |
| EBITDA margins | 14–16% |
| Net debt | ~£200m |
| CAC | £12 |
| Churn | 22% |
| Capex | £8–12m |
| COGS reduction | 15–20% |
Preview = Final Product
THG BCG Matrix
The file you're previewing on this page is the exact THG BCG Matrix report you'll receive after purchase—no watermarks, no demo content—fully formatted and analysis-ready for immediate use in presentations or strategic planning.











